Harpreet Singh Dhindsa

Harpreet Dhindsa practices at Fresno Dialysis in Fresno, California.

Harpreet Dhindsa's NPI, 1801864020, was assigned on March 14, 2006. Harpreet Dhindsa graduated from Government Medical College Patiala in 1994. Harpreet Dhindsa's California license number on file is A64349.

Harpreet Dhindsa's primary practice is Fresno Dialysis, at 4753 W Shaw Ave, Fresno, CA 93722 in Fresno County. The practice phone is (559) 277-3070.

Harpreet Dhindsa's primary practice is Fresno Dialysis in Fresno, California. Harpreet Dhindsa is also affiliated with Community Regional Medical Center. The medical group on file is The Nephrology Group, Inc. Dmand AI also links Harpreet Dhindsa to 2 more hospitals, 5 dialysis centers and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Harpreet Dhindsa practices, 9 sites in all. Vendor and product names are available with a free account.

Nephrology is Harpreet Dhindsa's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Harpreet Dhindsa is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Harpreet Dhindsa's licenses on file in 2 states: California and New York.

Dmand AI lists acute kidney failure, chronic kidney disease, fluid and electrolyte imbalances, kidney cysts, kidney disease and parathyroid gland disorder among the conditions Harpreet Dhindsa treats.

CMS data shows 10,926 Medicare services from Harpreet Dhindsa across 40 procedure codes in 2024, for 781 Medicare patients. Medicare paid $329,855 for them.

CMS counts 781 Medicare patients who saw Harpreet Dhindsa in 2024. The largest group is 65 to 74, with 269 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 52% are also on Medicaid. Their average risk score is 3.91, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Harpreet Dhindsa's median patient age at 70, with 48% women.

In 2024, Harpreet Dhindsa wrote 2,246 Medicare Part D claims for 481 patients. 80% of them were for generic drugs. CMS names the drug for 1,956 of them, across 39 drugs with 11 or more claims each, at $617,944 in total drug cost. In 2023, CMS named 1,536 claims across 32 drugs.

Harpreet Dhindsa accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Harpreet Dhindsa as offering telehealth.

CMS Open Payments shows 181 general payments to Harpreet Dhindsa from 31 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Amgen Inc. paid the most, $631.

Harpreet Dhindsa graduated from Government Medical College Patiala in 1994.

Harpreet Dhindsa is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.